Statistics for GenesInc (id:9905 GCO)

Valuation metrics

Market cap

323.86M

Enterprise value

816.14M

Trailing P/E (ttm)

84.76

Forward P/E

14.72

PEG ratio

14.72

Price/Sales (ttm)

0.14

Price/Book (mrq)

0.61

Enterprise Value/Revenue

0.36

Enterprise Value/EBITDA

13.45

Overview

Shares outstanding

11.22M

Float

10.26M

Shares short

530.10K

% Held by insiders

0.08%

% Held by institutions

0.93%

Average volume (10 days)

111.59K

Average volume (90 days)

Price summary

52-Week low

23.21

52-Week high

37.89

52-Week change

-6.75%

Beta

2.41

50-Day moving average

27.73

200-Day moving average

27.53

Dividends and splits

Forward annual dividend rate

0.68

Forward annual dividend yield

0.02

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

April 09th, 1973

Last split factor

2:1

Last split date

March 15th, 2006

Financials

Fiscal year

Fiscal year ends

February 03th, 2024

Most recent quarter (mrq)

July 31th, 2024

Profitability

Profit margin

-0.03%

Operating margin

-1.82%

Operational effectiveness

Return on assets

0.34%

Return on equity

-1.38%

Income statement

Revenue (ttm)

210.71

Revenue per share (ttm)

210.71

Quarterly revenue growth (yoy)

Gross profit (ttm)

1.10B

EBITDA

65.68M

Net income to common (ttm)

-7,338,000.00

Diluted EPS (ttm)

-0.87

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

45.86M

Total cash per share (mrq)

4.09

Total debt (mrq)

530.14M

Total Debt/Equity (mrq)

99.53

Current ratio (mrq)

153.30%

Book value per share (mrq)

47.40

Cash flow

Cash flow statement

113.90M

Levered free cash flow (LFCF)

82.18M